Related by context. All words. (Click for frequent words.) 50 #:# -# [003] 49 BUPHENYL R 49 IDACORP Inc. 49 PBTC 48 WGNB Corp. NASDAQ 48 FOR DIABETES 48 Declares Dividend Quick Facts 48 WGNB 48 Basilea Toctino R 48 NRIM 47 relapsed MM 47 CALGB # [002] 47 By JENNIFER LEARN 47 ALHC 47 Rien Long DT 47 Adverse Event 47 Daxor 47 LOCAL LAW ENFORCEMENT 47 CENTERS FOR DISEASE CONTROL 47 CAPITAL TRUST 47 POL PRO 46 CODE § 46 ACR# ACR# 46 SHR VIEW 46 Source Lipper 46 HBeAg negative patients 46 retrospective observational study 46 CAPITAL HOLDINGS 46 NSABP B 46 Organization QIO 46 Tredegar Corporation 46 Phase Ib II 46 Delcath Phase III 46 STRAT 46 Patient Registry 46 Hemodialysis Patients 46 CLARITY study 45 Phase Ib Clinical Trial 45 THOMPSON CREEK METALS 45 ANNOUNCES FILING OF 45 CHAMPION PCI 45 NANOTECH 45 Renal Cell Carcinoma RCC 45 GROUP LIMITED ABN 45 GLEN ALLEN 45 RU EUROPE ASIA EEU 45 R vitespen 45 ARCOXIA 45 Shionogi Pharma Inc. 45 ENTB 45 PHARMACEUTICALS INC 45 phase IIIb 45 ISTODAX ® 45 ASSAY 45 MSDH 45 LAUDERDALE Fla.FL 45 SPONSORSHIP DEAL 45 CompNewsNetwork 45 EFNS 45 CELGENE 45 INTERNATIONAL INC 45 Welichem 45 Deadline Approaching 45 UHPP 45 Investigational Drug 44 LAND DEVELOPMENT 44 EDUC 44 COVIDIEN 44 HoFH 44 SERVICES CORPORATION 44 Systemic Sclerosis 44 KL WN 44 ACEI 44 Prospective Randomized 44 Clavis Pharma ASA 44 FORCE PROTECTION 44 INFORMATION SYSTEMS 44 ARIXTRA 44 Developmental Evaluation 44 REVIVE Diabetes 44 Alitretinoin 44 FINAL RESULTS 44 Postgraduate Course 44 INCOME TRUST 44 RU EUROPE EEU EMRG 44 BIOPHARMA 44 Procyon Biopharma 44 CLGX 44 CONT 44 Arno Therapeutics 44 ATACAND 44 Omacetaxine 44 REMINYL ® 44 Curon Medical 43 Kahalalide F 43 Ocular Pharmacology 43 multicenter phase 43 Treprostinil 43 WAREHOUSING 43 SinuNase ™ 43 ANIMAL HEALTH 43 FDA Approvable Letter 43 Phase 2b Trial 43 NEAP 43 ISOCOUNTRY3 43 Matria Healthcare Inc. 43 HCV Protease Inhibitor 43 ICAEL 43 ANALYTICAL 43 CAPITAL CORP 43 INSURANCE CO. 43 FLEXTRONICS INTERNATIONAL LTD 43 COMPANIES INC. 43 www.portlandalliance.com 43 E2 CLO 43 CAPRA 43 MCGHealth Children Medical 43 MOTOR VEHICLES 43 INCORPORATED IN 43 Severe Sepsis 43 STUDY RESULTS 43 Comtech AHA Corporation 43 Solid Tumors criteria 43 Medicare Beneficiaries 43 Tobacco Quit Line 43 phase IIb study 43 Pregnancy Outcomes 43 MANAGEMENT INC. 43 Phase 2b Clinical Trial 43 Primary Care Providers 43 ST Segment Elevation 43 RU EEU EUROPE ASIA 43 glucocorticoid induced osteoporosis 43 VEHICLE WITH 43 GELA 43 plus COPEGUS 43 Donated Dental Services 43 Prolongs Survival 43 LigoCyte Pharmaceuticals 43 ALR Technologies 43 CAPITAL INC. 43 HOMES INC. 43 Fresenius Biotech 43 Cutaneous T 43 Cancer Incidence 43 Diamyd Medical 43 EBMT 43 COMPANIES INC 42 Cedartown GA 42 ADVISORIES 42 ANNOUNCES PARTNERSHIP WITH 42 CEPHALON 42 MEDICATIONS 42 Earns Accreditation 42 patientswith 42 INDUSTRIES INC. 42 NABTT 42 WE WILL CONTINUE TO 42 PEG IFN 42 GEORGIA PACIFIC 42 HEALTHCARE INC. 42 TAX LAW 42 DEVELOPMENT COMPANY 42 Biomed Realty Trust 42 ROYALTY TRUST 42 PIATT 42 Pollution Prevention Assistance 42 American Nephrology Nurses 42 FLU VACCINE 42 PCI Biotech 42 Chronic Obstructive Lung 42 ANNOUNCES FOURTH QUARTER 42 NCAL 42 Addictive Diseases 42 FSRV 42 PHILPOTT 42 Bosutinib 42 Gynecologic Oncology Group 42 CELANESE 42 CAROLINAS 42 DEPARTMENT OF LABOR 42 KidSational Inc. 42 SSc patients 42 PHARMA INC. 42 Pediatric Oncology Branch 42 UTILIZATION 42 cUTI 42 Myeloproliferative Neoplasms 42 HOLDINGS LLC 42 NYSE TGX 42 CIBMTR 42 CYGX 42 STOCK SYMBOL 42 RIGScan R 42 NEW RESEARCH 42 OZURDEX 42 Phase 1b trial 42 LORILLARD 42 HOLDINGS PLC 42 MBCN 42 ENVIRONMENTAL PROTECTION AGENCY 42 SINCE JANUARY 42 alendronate sodium 42 EXCISE TAX 42 INITIATE 42 MaruEnergy Caribbean Ltd. 42 ACQUISITION CORP. 42 GW# [003] 42 Doyon Utilities 42 Acute Decompensated Heart Failure 42 journal Transfusion 42 ABCSG 42 PHASE III 42 TRADING SYMBOL 42 ENERGY GROUP 42 HLDGS 42 DRILL HOLE 42 mycophenolate mofetil MMF 42 neovascular age 42 Multiple Ascending Dose 42 COMPLETES ACQUISITION OF 42 ADRE 42 FINANCIAL GROUP 42 LISTING OF 42 Hyperlipidemia 41 MEDIA INC. 41 number NCT# ClinicalTrials.gov 41 BCIRG 41 FRESENIUS 41 REPORTS THIRD QUARTER 41 seropositivity 41 Receives Marketing Authorization 41 PHARM 41 papillary renal cell carcinoma 41 Phase 2b kidney transplant 41 INSURANCE SERVICES 41 BANCORP INC. 41 Severe Asthma 41 Soft Tissue Sarcoma 41 Urocortin 2 41 Acute Ischemic Stroke 41 NCQA accredited 41 RELATES TO 41 Orqis Medical 41 LIEN 41 IG RTS ;) 41 Tobacco Quitline 41 Bendamustine 41 Chronic Heart Failure 41 MORTGAGE LENDING 41 CO INC 41 stage IIIB 41 MEDMARX 41 Active Biotech AB 41 Kidney Disease Outcomes 41 Cervical Cancer Screening 41 ATTAIN 41 EMRG POL 41 STREAMLINE 41 PANVAC VF 41 NOVARTIS 41 AUTOMATIC WITH OVERDRIVE 41 Score TOS 41 ASTHMA 41 METLIFE 41 FHCC 41 AETERNA ZENTARIS 41 cisplatin gemcitabine 41 Non inferiority 41 GRAVITAS trial 41 pharmacokinetic PK study 41 Adult Immunization 41 APEX AMI 41 st Annual Meeting 41 AIQ 41 FINANCIAL MANAGEMENT 41 Biological Effects 41 Late Breaker 41 ENERGYSOLUTIONS 41 Marrow Transplant Research 41 UAHC TN 41 DIRECTORY OF 41 THYROID 41 WAS CONTACTED 41 prospective multicentre 41 fludarabine cyclophosphamide 41 Unizan Financial 41 SERVICES INC 41 Onrigin TM 41 CVS Caremark Specialty Pharmacy 41 ALL LANES 41 recurrent glioma 41 Eni Norge AS 41 ABBOTT LABORATORIES 41 WERE UP 41 PSORIASIS 41 CREDIT SUISSE GROUP 41 Southeast BIO SEBIO 41 microbiologically evaluable 41 MCOA 41 Myelodysplastic Syndromes MDS 41 Tumor Registry 41 Phase Ib study 41 PROSHARES 41 Cintredekin besudotox 41 ACR# responses 41 OBJECTION TO 41 Carotid Revascularization Endarterectomy vs. 41 evaluating tivozanib 41 PACIFIC NORTHWEST 40 Aryplase 40 familial amyloidotic polyneuropathy FAP 40 #st Annual Meeting 40 INTERVAL 40 Nasdaq CYCC Nasdaq CYCCP 40 serum leptin 40 TRI.TO 40 Panzem ® 40 AA Amyloidosis 40 rALLy trial 40 ASSOCIATED ESTATES REALTY 40 WorldHeart Announces 40 Cloretazine 40 Molecular Detection 40 Systemic Lupus Erythematosus SLE 40 STENT 40 AVENTIS 40 AIR2 Trial 40 Primary endpoints 40 recurrent glioblastoma multiforme 40 § #.# [002] 40 Laryngeal Cancer 40 SABCS 40 clinico pathological 40 BZC 40 CONSTRUCTION INC. 40 PROV 40 Acute Coronary Syndromes ACS 40 N. Kirtskhalia 40 dose escalation clinical 40 WORKFORCE DEVELOPMENT 40 huN# DM1 40 Medically Underserved 40 Magyar Bancorp 40 IIa clinical 40 abstracts summarizing 40 SHARES FALL 40 Nucryst Pharmaceuticals Corp. 40 evaluating mipomersen 40 BROADHURST 40 Colorectal Cancer Screening 40 Acute Stroke 40 APEX AMI trial 40 INTERACTIVE ENTERTAINMENT 40 Proc Am Soc 40 Glatiramer acetate 40 Malpractice Insurance 40 Nurse Anesthetists 40 Onrigin 40 SCCHN 40 AmpliMed 40 CAMPATH 40 Triapine R 40 FORD FUSION 40 desvenlafaxine succinate 40 Aggrenox ® 40 ASSIGNMENT OF ERROR 40 SECOND QUARTER FISCAL 40 advanced hepatocellular carcinoma 40 Podium Presentation 40 clinically evaluable 40 PROGRESS ENERGY 40 CAPITAL BUDGET 40 epoetin alpha 40 PSC Approves 40 IL# PE#QQR 40 REAL ESTATE DEVELOPMENT 40 ZACTIMA 40 INCLUDING CONTACT DETAILS 40 TENET HEALTHCARE 40 GeorgiaCares 40 Welcomes Newest 40 BORSA 40 ANNOUNCING THE 40 CRMD# 40 PITNEY BOWES 40 NAGC 40 Androxal TM 40 ASBMR 40 GIRLS TEAM 40 System NGHS 40 STIFEL FINANCIAL 40 Imedex 40 CONSTRUCTION MATERIALS 40 Thrombosis Research 40 Expedited Review 40 Artificial Cornea 40 Bimonthly 40 Integrative Healthcare 40 Onconova Therapeutics Inc. 40 Lauds Passage 40 biostatistical analysis 40 Tyrosine Kinase Inhibitors 40 ANNOUNCES APPOINTMENT OF 40 AND EARN 40 RealEstateRama â € 40 CALGB 40 lorcaserin Phase 40 QOPI 40 Phase III psoriasis 40 BENEFITS FROM 40 Arterial Hypertension 40 MEVACOR 40 Immunization Registry 40 Febuxostat 40 Phase III Clinical Trial 40 CAMERON INTERNATIONAL 40 CAS #-#-# Market [001] 40 STRUCTURE AND 40 Gerontological Nursing 40 Initiative K DOQI 40 PCWP 40 rALLy clinical trial 40 TECHNOLOGIES GROUP INC. 40 TECHNOLOGY INC. 40 WIND ENERGY 40 Raleigh NC SBWIRE #/#/# 40 Physical Therapy Specialists 40 Endocrine Society #st 40 TEC #OL 40 HEALTH SERVICES 40 ACC NCDR 40 Scancell Holdings Plc 40 amphetamine methamphetamine 40 Gynecological Cancer 40 Echocardiographic 40 Granted Orphan Drug 40 timolol maleate 40 clevidipine 40 ORGANIC GROWTH 40 GCI Nasdaq GNCMA 40 Initiates Phase 2b 40 WEEKS TO 40 INTERCEPTS 39 AASLD 39 Uterine Fibroid 39 LUMINATE 39 Thousand Oaks Kiwanis Club 39 Radiation Oncologists 39 Rocky Mountian 39 Physician Workforce 39 BioGeneriX 39 PUBLIC TRANSIT 39 COPERNICUS 39 Independent Evaluator 39 ORAL HYCAMTIN 39 Physician Referral 39 Phase III HEAT 39 FISHERMAN 'S LANDING 39 Acute Liver Failure 39 Assistance Authority NCSEAA 39 Urologic Research 39 busulfan 39 ISPOR 39 Governor Proclaims 39 Pharmacologic 39 Zentaris GmbH 39 DISPOSAL 39 BY MONIQUE 39 RECIST Response Evaluation Criteria 39 CAS #-#-# Market [003] 39 BENICAR 39 fosbretabulin 39 CALPINE 39 ASCO GU 39 Certican 39 Clinical Therapeutics 39 Med eXpert 39 thetreatment 39 HEALTH SCIENCES 39 Folic Acid Campaign 39 Myelodysplastic Syndrome MDS 39 MC# [001] 39 KeyNeurotek 39 CUSTODIAN 39 National Oncologic PET 39 PrC Nuveen 39 WATER QUALITY 39 Tripep 39 Merz Pharmaceuticals LLC 39 Solid Tumors 39 REACH Registry 39 allogeneic hematopoietic stem cell 39 Pivotal Trial 39 Adult Stem Cell Therapy 39 satraplatin Phase 39 TPIM 39 Polio Survivors 39 NSABP 39 Microalbuminuria 39 APPLICATION OF 39 CELESTICA 39 SERONO 39 Pediatrix Acquires 39 prospectively defined 39 CLO RP 39 Tennessee BCBST 39 SAME AS 39 RSY 39 PTI MIJ 39 histamine dihydrochloride 39 HQH 39 HANDLEY 39 MAG Mutual 39 Swine Flu Hotline 39 Anticoagulation 39 RAMP UP 39 MOST ACTIVE 39 Cancer iSBTc 39 EPS ESTIMATE 39 FOOD PRODUCTS 39 Histopathological 39 pegylated interferon alfa 2b 39 GROUP HOLDINGS LIMITED 39 ALBERTO CULVER 39 somatostatin analog 39 Prostate Cancer Screening 39 REAL ESTATE INVESTORS 39 Quinamed 39 ACCF AHA 39 ENVIRONNEMENT 39 hypereosinophilic syndrome 39 DIAGNOSTIC 39 CHARLES SCHWAB 39 Acute Coronary Syndromes 39 Phase Ib clinical 39 Advanced Renal Cell 39 IMiDs ® compound 39 AACR #st Annual Meeting 39 Allergy Sinus 39 Allogeneic 39 Demonstrates Sustained 39 UNICARE 39 Mailers Technical 39 AMENDMENT TO 39 Electronic Prescribing 39 Sets Priorities 39 REGS 39 DATA SYSTEMS 39 MYTHOS trial 39 Healthy Living Academies 39 COMMUNICATIONS INC 39 ELIGIBLE FOR 39 Sidec 39 IN NORTH CAROLINA 39 ICAAC IDSA 39 REALITY Trial 39 AACVPR 39 Cytogenetic 39 DRIVE SMART 39 Talisman Energy Norge AS 39 COMPLY 39 ABOVE GROUND 39 DIFFERENTIAL 39 ASNR 39 Military Installations 39 Receives Accreditation 39 MXB 39 STEEL INDUSTRY 39 Interventional Pain Management 39 prospective multicenter 39 CLARINEX D 39 Kidney Disease Education 39 WDEQ 39 Doxil ® 39 PILOT PROGRAM 39 Multicenter Study 39 Hematologic Malignancies 39 BUFORD Ga. BUSINESS WIRE 39 Platinol ® cisplatin 38 NCNG 38 Amorcyte 38 PHYSICAL THERAPY 38 www.michaeljfox.org 38 FGDC 38 ENERGY SYSTEMS 38 ColonSentry test 38 TGZ 38 BR.# 38 Biodesix 38 FACTS ABOUT 38 histologically confirmed 38 #nd EORTC NCI 38 Naturopathic Medical 38 NYSE EFX 38 Colon Rectal 38 GCLA 38 pharmacokinetic characteristics 38 Cardiovascular Therapeutics 38 randomized Phase III 38 Clinicaltrials.gov 38 CAPITAL CORP. 38 ENGLAND HOPES 38 Phase #b/#a clinical 38 Comprehensive Cancer Centers 38 BOSTON PROPERTIES 38 SCRIPPS 38 FINANCIAL ASSISTANCE 38 fluticasone propionate FP 38 Specialty License Plate 38 sorafenib Nexavar 38 HOW YOUNG 38 Groundwater Monitoring 38 Phase 1b clinical trials 38 Zenvia Phase III 38 PRODUCTIONS INC. 38 multicenter randomized controlled 38 Sanochemia Pharmazeutika AG 38 STRATA 38 Cardiotoxicity 38 ACCLAIM 38 Group RTOG 38 Dossier IMPD 38 Lung Transplantation 38 lorvotuzumab mertansine 38 Reproductive Specialists 38 BCNS 38 GCSA 38 Donor Registry 38 PRESCRIPTIONS 38 INTERNATIONAL FINANCE 38 WORKING GROUP 38 EVERGREEN ENERGY 38 WEBCAST OF 38 DQC 38 Medical Equipment Suppliers 38 EVALUATE 38 Cloretazine ® 38 Cellular Immunotherapy 38 Bipolar Disorders 38 retrospectively analyzed 38 MINING LTD 38 POLYMERS 38 HFSA 38 piperonyl butoxide 38 Receives Endorsement 38 Curative Health 38 Vascular Disease Foundation 38 Stereotactic Body Radiation Therapy 38 Chemophase 38 QUAL 38 Clinical Virology 38 agalsidase alfa 38 EMERSON ELECTRIC 38 Alzheimer Caregivers Support 38 INTERCEPT platelets 38 liposomal formulation 38 CardioFit 38 HDAC Inhibitor 38 NASDAQ PWX 38 CRVO 38 phase IIa clinical 38 WASTEWATER 38 Talabostat 38 GEM OS1 38 INTERNATIONAL HOLDINGS LIMITED 38 achieved sustained virological 38 DEDUCTION 38 Naturopathic Physicians 38 Islet Transplantation 38 Thrombolysis 38 NC OPENPRESS 38 unstable angina pectoris 38 Marrow Transplant 38 Minority Entrepreneurs 38 Genova Diagnostics 38 CaroMont Health 38 associated vasculitis 38 Phase 1a clinical 38 Tissue Banks AATB 38 lymphoid malignancies 38 HYPERTENSION 38 metastatic gastric 38 PRTR 38 Malignant Lymphoma 38 Gastric Cancer 38 Trigeminal Neuralgia 38 relapsing multiple sclerosis 38 Intervention Trial 38 Dr. McHutchison 38 NorDiag ASA 38 ANNUITY 38 Parathyroid 38 Treatment Outcome 38 Novel Therapeutic 38 Panel Endorses 38 AFTER LOSS 38 Centers FQHCs 38 Cimzia TM 38 AIDGwinnett 38 MASTER FUND 38 Digital Mammographic Imaging 38 Orphan Designation 38 metastatic malignant 38 idursulfase 38 By DAVID BORGES 38 PROPEL 38 HUMAN RESOURCE 38 Trandolapril 38 histological subtype 38 Axium Healthcare Pharmacy 38 Gynecologic Cancer 38 Gendux 38 mITT population 38 LifeHealthCare Inc. 38 FEDERAL SIGNAL 38 Simulect 38 SENIOR GAMES 38 CHINA LIFE INSURANCE 38 Superficial Femoral Artery 38 LACI 38 Tuomey Healthcare System 38 Alocrest 38 AMERICAN GREETINGS 38 JM Tull 38 Histocompatibility 38 CRIMINAL TRESPASS TO 38 DiscoveryBioMed 38 EÖ 38 GLUCOSE 38 paclitaxel poliglumex 38 ArriveNet Sep 38 alpha antagonist 38 Hypertriglyceridemia 38 DENS 38 AAPM 38 ISMB 38 SOLUTIONS INC. 38 ovarian cancer biomarker 38 WCOG 38 Pediatric Urology 38 Pharmaprojects 37 Bankers Association OBA 37 Hematological 37 Practicing Clinicians Exchange 37 Clinical Lipidology 37 HOLDINGS INC 37 CONFUSION OVER 37 ORTHO 37 ENERGY CORP 37 DESIGNATION 37 TG MV 37 FIRSTENERGY 37 SCHEDULES 37 UEGW 37 DIALYSIS 37 Biofrontera 37 MOODY 'S INVESTORS SERVICE 37 Corporate Responsibility Officers 37 Elisabeth Lindner CEO 37 UNITEDHEALTH GROUP 37 PETD 37 metastatic pancreatic 37 Cardiovascular Magnetic Resonance 37 INVESTMENTS LTD 37 HUNT VALLEY 37 Tobacco Cessation Program 37 AccuBoost 37 OvaDx 37 Diabetes Complications 37 Newborn Screening Program 37 Dental Hygienists 37 Provider Synergies 37 Metametrix Clinical Laboratory 37 CARTI Foundation 37 Unstable Angina 37 Source MDx 37 Drug Abuse Treatment 37 Antisoma AS# 37 FNBA 37 NSTEMI 37 NeoRecormon 37 THE INSTITUTE FOR 37 MMI Associates 37 BreastCare 37 histone deacetylase HDAC inhibitor 37 Val HeFT 37 ALSK 37 PEAKE 37 JAK2 Inhibitor 37 Velcade bortezomib 37 ATMOSPHERIC 37 Adult Bereavement Support 37 ENDEAVOR IV 37 GLOBAL HOLDINGS 37 COVERAGE FOR 37 Gynecologic Oncologists 37 Novel Inhibitor 37 RINKER 37 BioCell 37 Wilcoxon rank sum 37 CardioDynamics CDIC 37 novel histone deacetylase 37 CSPG 37 COMPARING THE 37 Honduras Lesotho Madagascar 37 HYVET 37 randomized Phase 2b 37 AMERICAN PUBLIC EDUCATION 37 underwent CABG 37 NMR Spectroscopy 37 ADHERE 37 NFID 37 CARDIOLOGY 37 VALUE FUND 37 Unibased Systems Architecture 37 MOLECULAR 37 ARVO 37 CC genotype 37 multivariate Cox 37 APPLIES FOR 37 ALLERGAN 37 Newborn Screening 37 LOCAL LAW 37 Pamidronate 37 Reimbursement Hotline 37 TZG 37 AIR POLLUTION 37 DIAGNOSTICS 37 NAGEL 37 Renal Physicians 37 Flu Immunization 37 BLOOD TEST 37 Skin Care Specialists 37 HIVMA 37 Nephrology Renal Week 37 InterAgency 37 McKesson EHR 37 Rescare 37 MacuCLEAR 37 NONPROFIT 37 Hematology Oncology Associates 37 GLOS 37 BUDGET PROPOSAL 37 BANKING GROUP 37 AAKP 37 ACOMPLIA R 37 Matthew Rojansky 37 Representative Calvin Smyre 37 Developmental Therapeutics 37 HEALTHSOUTH Rehabilitation Hospital 37 IS AXED 37 thymoma 37 phase IIa 37 Educators PAGE 37 CAMPAIGN FINANCE 37 EDP Biotech 37 demonstrated antitumor activity 37 PRODUCTS INC. 37 IMPLANT 37 Stenting Trial CREST 37 BCR ABL inhibitor 37 Surgeons Perform 37 Radiation Therapy Oncology 37 Electrical Apprenticeship 37 MEND CABG II 37 Yondelis ® 37 EOTC Family Center 37 hepatocellular carcinoma HCC 37 depsipeptide 37 HOLDINGS CORPORATION 37 Screening Trial DMIST 37 Mel Watt D 37 samalizumab 37 Clinical Pharmacy 37 LAW CENTER 37 LDH lactate dehydrogenase 37 plerixafor 37 HSCT 37 Immune Mediated 37 Stent Thrombosis 37 www.dickyarbrough.com 37 WATER RESOURCES 37 OF DESPAIR 37 Rockwood Holdings Inc 37 HomeOwnership 37 AMEREN 37 SERVICES LTD 37 Liquid Tissue 37 ImmuKnow assay 37 Urologic 37 Amrubicin 37 ELI LILLY 37 Biospecimen 37 BCBSNC Foundation 37 MEDTRONIC 37 OvaRex MAb 37 Special Needs Plan 37 AQUATIC 37 Sharon Omahen University 37 Peachcare 37 MEASUREMENT 37 Decompensated 37 ImmuKnow R 37 IS CLEAR 37 BOOK ON 37 Advanced Heart Failure 37 HLA DRB1 * 37 prospective observational 37 Biological Therapy 37 TRUST INC. 37 BPRW BW 37 www.piedmontng.com 37 Alzheimer Caregiver Support 37 PEPCO HOLDINGS 37 Racial Ethnic Minorities 37 MORNING AFTER PILL 37 Theriogenology 36 Triolex 36 STROM 36 Therapeutics TCT 36 CONSULT 36 RETIREMENT PLAN 36 Mailing Address 36 INVESTMENT GROUP 36 tocopheryl acetate 36 metastatic RCC 36 Zenvia ™ 36 PharmD MPH 36 LIBERTY MUTUAL 36 IARU Region 36 Hematology Oncology Centers 36 SMARTER Balanced Assessment 36 vismodegib 36 Maryann Mrowca 36 sunitinib malate 36 WYETH 36 DEVELOPMENT CORP. 36 FITNESS FIGHT 36 Cervical Cancer Awareness 36 IMMUNE 36 CRIM 36 Remote Sensing ASPRS 36 #mg #mg #mg [001] 36 Hematology Meeting 36 LUANN 36 Affimed Therapeutics AG 36 VENTURES INC. 36 Resten MP 36 RECEIPTS 36 sustained virological response 36 Microwave Ablation System 36 NCCTG 36 RhuDex ™ 36 CIPH 36 FIRST AMERICAN 36 OCuSOFT 36 COPAXONE R 36 JUST MAKE 36 Poyner Spruill LLP 36 laparoscopic radical nephrectomy 36 pediatric acute lymphoblastic 36 DBLCI OY 36 Society CTOS 36 BCG refractory 36 Publix Pharmacies 36 Paroxysmal Nocturnal Hemoglobinuria 36 Behavioral HealthCare 36 AATCC 36 TRI 36 Zweidler McKay 36 Lysaker Norway 36 SIMPADICO 36 Oncologic 36 RAPAFLO R 36 JCAHO accredited 36 MDPA 36 ACTIVE 36 NYHA 36 AMERIGROUP Foundation 36 Ambulatory Surgery 36 Metal Toxicology 36 EARNS FIRST 36 Mantle Cell Lymphoma 36 GROWTH FUND 36 restenotic lesions 36 oral treprostinil 36 Digestive Diseases Week 36 observational cohort study 36 PCSA 36 SUTENT ® 36 pain palliation 36 BUSINESS INSIDER 36 RYDER SYSTEM 36 HUMAN CAPITAL 36 PROJECT MANAGEMENT 36 Preclinical Study 36 antiretroviral naïve 36 TRIPLE CROWN